The Netherlands Area Biotech Discussion Group
June 20, 2024
Prioritizing Patient Involvement: The Key to Successful Drug Development | Leiden, Netherlands | 20 June 2024 16:30 - 18:30 CET
In our collective endeavor to develop innovative pharmaceuticals to fight diseases, we embark on a journey of discovery, innovation, and the meticulous generation of data. This data eventually converges into a comprehensive new drug application. However, beyond the stringent scientific evaluation and regulatory approval process lies the true litmus test: the patients' experience with the drug.
It is essential to consider whether the drug effectively addresses patients' needs, if it alleviates their most burdensome symptoms, if it's tolerable, if adherence to the treatment is feasible, and if the dosing schedule is practical. These are pivotal questions we should ask ourselves throughout the drug development journey.
Recognizing the invaluable insights patients provide, it is fundamental to involve them from the get-go. In our upcoming event, van Tomme will shed light on global trends in patient engagement and provide concrete examples demonstrating the integration of patient perspectives into the drug development process. To complement van Tomme’s industry perspective, Veltrop-Duits will share the Dutch regulator’s perspective, underscoring the significance of patient participation in clinical research.